Healthcare Businesses for Sale and Investment Opportunities in North America

- Business primarily focused on gene therapy and biomarker/diagnostic services, with a specific emphasis on neurological conditions such as ALS, Parkinson's, Alzheimer's, and TBI. - Offers biomarker testing as a CRO for pharma and researchers. Additionally, it is involved in the development of Adeno-Associated Viruses (AAVs) for neurodegenerative disorders, with a particular focus on inflammation and targeting neurons and glial cells. - Has patented and licensed technologies from premier research institutions. - The company generates revenue on a per research project basis, with an average project duration of 3 months and an average value ranging from $8,000 to $25,000. It has successfully completed projects for 10 different research companies since its inception. - The company is currently engaged in a gene therapy research project involving 2,600 samples. - There are 2 permanent employees, additionally, we have a few temporary employees/interns as well.

- The business is a known medical and non-medical PPE supplier to various counties, hospitals, senior homes, rehab facilities, and universities. - The business has long-term blanket contracts with states and counties hereby providing strong revenue visibility. - They have a long-standing partnerships with highly rated, credible 50+ manufacturers and suppliers and best in class ERP/CRM/accounting systems backed processes from procurement to logistics to delivery. - The business has 85 regular clients. - Our business is based in India and we are acting as an advisory firm for the business that is looking to sell out in the US. - More details will be shared at a later stage.

- Company plans to develop a fully entitled 120 unit 65+ independent /CCRC (Continuing Care Retirement Community). -Marketing Objectives: • To obtain a 5% monthly increase in customer base. • To achieve nationwide publicity of the business brand. • To ensure online followership of business brand. Statistics. - The market size value of the assisted living facility (ALF) in the United States is forecasted to grow from $83.2 billion in 2020 to 119.2 billion by 2027 at a CAGR of 5.3%. It further revealed that a resident in an assisted living community in California will pay $4,500-5,000 per month on average. -Minimum IRR of 20% and COC return. -An excellent opportunity to build at least 98 currently approved and up to 120 homes on a beautiful 2.2-acre level parcel in the quiet Hilltop neighborhood. The incredible location offers sweeping views of the North Bay and overlooks a natural canyon. Currently approved plans provide a mix of 3, 2, and 1-bedroom homes; which all units would safety proofed and equipped to fit the lifestyles of all tenants. • CCR rates (per month) O Classic studio. $4,350. O Alcove studio $4,550. O Traditional one bedroom $4,850. O Classic two-bedroom $5,500. O Supreme two-bedroom $5,500-10,000. (Rates are not set, they are conservative to the current market and are subject to increased change) Private Independent Senior Living rates vary with regards to amenities, services, and living arraignments provided. Rates may range from $4,600-$5,500 seeing that more hands-on 24/7 care services are not being provided.

1. The company seeks funding for the acquisition of healthcare/home healthcare companies, leveraging the retirement of current owners as an opportunity for strategic expansion. 2. The target companies for acquisition are primarily driven by the retirement of current owners, presenting a favorable market condition for potential investments. 3. The purchase prices for the targeted companies range from $1 million to $15 million, providing a diverse range of investment opportunities within the Home Healthcare industry. 4. The promoter has a background as an experienced firefighter and EMT, bringing a unique combination of healthcare and operational expertise to the acquisition strategy. 5. One of the potential acquisition targets based in Massachusetts demonstrates a strong financial performance, generating an annual turnover of USD 18 million with an impressive 40% EBITDA margin, indicating a lucrative investment opportunity. 6. The current owners' retirement and employee retention issues provide a strategic opportunity for the acquirer to enhance operational efficiencies and improve cash flows post-acquisition. 7. The company's portfolio of products and services includes skilled nursing, LNA, and at-home healthcare, reflecting a comprehensive range of offerings within the home healthcare sector.

The company has more than 400 clients. The business has a 3% growth rate. We assist over 400 independent pharmacies with the 340B drug discount program. Both owners are pharmacists and one owner sold the previous company to McKesson.

COMPANY PROFILE. A World of Excellence in In-Vitro Diagnostic Kits & Reagents. Has a history of over 36 years in successfully developing, designing, producing, selling and marketing a complete line of diagnostics reagents and kits for use in Hospitals, Medical Laboratories, Research Institutions within the Health Care and Pharmaceutical Industries. Its strength stems from a foundation of knowledge and experience in product development with a commitment to quality and cost effectiveness in the biotechnology field. Products are developed, designed and produced with unique formulations using state-of the-art technology. All in-vitro diagnostics reagents and kits are produced using GMP rules and regulations of the USA FDA. Products are marketed in, USA and Globally. Presently it has three international branches (India, China, and Latin America) and a worldwide distribution network. Main Mission is to produce and distribute USA Made and FDA approved IVD Kits and Reagents globally. OEM, Private Label, Bulk Reagents/Components, CRO and Technology Transfer Services are available. Prestigious Clients We are very proud of our high quality FDA approved product lines, particularly, which are currently being sold to institutions such as: CDC, NIH, Prestigious Universities, Research Centers, Cancer Research Institutions, VA and other Prestigious Private Hospitals. Biotron Diagnostics has been certified as a US Government Supply Administration Federal Vendor. Products are competitively priced. Mission is to produce and distribute high quality and low cost USA Made and FDA approved IVD Kits and Reagents, offering OEM Service, Private Label, Bulk Reagents/Components, and IVD Technology Transfer in the field of Laboratory Medicine. Current Licenses: FDA Registered Establishment CFG- Free Sale (Current) California PHFDA IVD Manufacturing ISO 13485-2016 (IAS) CE Mark Certified 510 (K) s 120 C FG= List of FDA approved IVD Kits City of Hemet. Products Summary company develops, produces, provides OEM services and distributes high quality and low cost in vitro diagnostics kits and reagents for Clinical Chemistry (Routine and Research chemistries - similar to Sigma and ultra-sensitive Sickle Cell Kits & Controls) ), Immunochemistry (ELISA/CLIA), Urinalysis, Serology, Fertility, Coagulation, Blood Banking, Rapid Diagnostics, Drug Screening, Biomarkers (Tumor Markers and Cardiac Tests), Infectious Diseases Rapid Tests (Export only), Bulk Clinical Chemistry & Coagulation Reagents for Instruments, Calibrators, Controls & Standards, Diabetes (Dr. G Glucosemeter & Test Strips (Dr. G Smart 1, Dr. G Smart 2, Dr. G Smart 3) Hematology (Buffers & Reagents), Microbiology (Media, Stains and Reagents), Histology and Cytology (Buffers & Reagents), Veterinary test kits and Petnostics and Molecular Diagnostics (Genomics) Innovated Gene Testing Assays for Cancer and Infectious Diseases. Most Popular & Best Seller Popular Products include advanced Sickle Cell Kit and Sickle Cell Controls (Sensitivity correlates with Hemoglobin Electrophoresis), Biotin-Streptavidin Technology based ELISA Kits, Most advanced UroFast Urine Reagent Test Strips, Dr. G Glycosometer, Research Chemistries, Infectious Disease Rapid Tests for Export, and Temperature Stable Culture Media (up to 60°C). Specialty Products includes ultra-sensitive tests for Fertility (Novel Pregnancy Test and Male Fertility), Dr. G Glucose meters + HBA1C), Serology (Rubella, SLE, ANA, RPR, FOB, Staph A, Strep A, Febrile Antibodies Kits: febrile Kit, Widal Kit 400, Widal Kit 800, Rose Bengal Kit, Dri. Dot Kits and H Pylori), Highly Sensitive Infectious Disease Rapid Tests (Strips & Cards) for for Export only (CE Mark, WHO) for Hepatitis, Human Immunodeficiency Virus 1+2, Treponema Pallidum, Neisseria Gonorrhoeae, Helicobacter Pylori, Malaria, Cholerae Vibrio Antigen (Ogawa/Inaba), Yesinia Pestis, Plague, Tuberculosis, Adenovirus, Rotavirus, A Streptococcus, Chlamydia Trachomatis, Procalcitonin test, Salmonella Typhi, Dengue Virus, Chagas, Zika Virus, and Precise Biomarkers (CEA, FOB, AFP, PSA, Fatty Acid, Troponin I, CK-MB, Myoglobin, C-reactive Protein, BioFast COVID-19 Assays (BioFast COVID-19 Antigen Test - (Professional Use Only), BioFast COVID-19 Antigen Home TestBioFast COVID-19 Antibody Test, BioFast iAMP COVID-19 Detection Test Kit (Multiplex Fluorescent Detection) BioFast COVID-19 Antigen (Saliva) Home Test* COVID-19 IgG/IgM Antibody Test* COVID-19 IgG/IgM Antibody Test with LF Reader* COVID-19 IgG-only Antibody Test* COVID-19 & M. pneumoniae IgG/IgM Antibody Combo Test* COVID-19 & M. pneumoniae IgG-only Combo Test* COVID-19 and Influenza A/B Antigen Combo Rapid Test* COVID-19 Antigen (Saliva) Test Strip}, *SARS-COV-2 RT-qPCR Assay. Molecular Diagnostics (HPV. Fifteen high-risk types Kits both in multiplex and genotyping formats, Chlamydia Trachomatis, Clostridium Difficile, Coxiella Burnetii, Neisseria Gonorrhoeae, Yesinia Pestis, Bacillus Anthracis, Francisella Tularensis, Haemophilus, Legionella, Listeria, Salmonella, Staphylococcus and Trichomonas Vaginalis), Immunofluorescent Assays (infectious Diseases —Chagas, Toxplasmosis, Hidatidosis, Syphilis, Triquinosis, Chlamydia trachomatis, Autoimmune Diseases- Anti-DNA, ANAHEp-2, AMA, ASMA, APCA, ANA, LMK, EMAIgA0) and Plasma Proteins ¬RID- human proteins, Combo Immunoglobulins (IgA, IgG, IgM) IgA, IgG, IgM, IgD, Complement C-3 and C-4 and others and Bio-Defense related test assays are researched, developed, formulated and Produced. Newest Products) includes 1. 25 (OH) Vitamin D ELISA (VDSP) 2. Active Vitamin B12 EIA 3. Urofast URS Reagent Test Strips 11 parameters 4. HPV DNA PCR Detection Kit 5. H. pylori Antigen feces ELISA 6. D r. G Glycosometer + HbA1C Combo Meter 7 Allergy Screen 8. Ds DNA ELISA 9. Immune Health IgG ELISA 10. HIV ½ Ag/Ab 4th Generation Rapid Test 11. Calprotectin Rapid Test 12. ANA Screen IgG ELISA 13. . Zika IgM Rapid Test 14. Chikungunya IgM Combo Rapid Test 15. Chlamydia Ag Rapid Test 16. Syphilis Rapid Test 17. Influenza A/B Rapid Test 18. COVID-19 R T (Antigen) both professional and do yourself home test 19. COVID- 19 RT (Antibody) 20. COVID- 19 Multiplex PCR Detection.

- A mental health and wellness institute, based in Utah. - Services include TMS (Transcranial Magnetic Stimulation) and neurofeedback (qEEG/brain-mapping), behavioral health, substance abuse treatment and our proprietary faith based educational program. - We target conditions like depression, anxiety, PTSD and addiction. - Our initiative is to build, own and manage inpatient and outpatient treatment centers within close proximity of existing Zion - Healing outpatient treatment centers, US military bases, and VA hospitals. - Currently, we are operating from 22 outpatient treatment centers nationwide. The company also has over 60 additional clinics in development to expand its footprint and profitability. - Our goal is to add 10-15 bed inpatient and detox centers to support our existing outpatient centers. - The investor will get stake only in this 1 center in Utah, where we will be first introducing the new services, and not in the other franchise units. - On an average, we get up to 150 patients per day. - We have State of Utah mental health license. - There are 14 permanent employees, who are registered psychiatrists and licensed mental health professionals. No additional contract employees are hired.